Editöre Mektup
BibTex RIS Kaynak Göster

COVID-19 ve Bir Prediktör Olarak C-Reaktif Protein Albumin Oranı

Yıl 2022, Cilt: 14 Sayı: 3, 77 - 78, 31.12.2022
https://doi.org/10.35514/mtd.2022.77

Öz

2019 yılının sonlarına doğru ortaya çıkan ve ilerleyen dönemlerde tüm dünyayı etkisi altına alıp pandemi ilan edilmesine neden olan COVID-19 hastalığına dair her geçen gün yeni bir bilgi ortaya çıkmaktadır. Ancak hastalığın klinik olarak takip ve tedavi aşamasında hangi hastaların daha yakın izlenmesi gerekliliği veya hangi hasta grubunun ağır hastalık açısından daha riskli olduğunun tespiti pik dönemlerinde artan sağlık sistemi üzerindeki yük göz önüne alındığında önemi artmaktadır. Pandemi gibi çok geniş kitleleri etkileyen ve sağlık hizmeti sunumunda kaynakların uygun yönetilmesini zorlaştıran durumlarda doğru triaj yapmak ve doğru hastayı doğru kaynaklara yönlendirmek gerekir. CRP Albumin oranı kolay erişilebilir, ucuz ve basit olması nedeniyle COVID-19 hastalarının yönetiminde kullanılanılabilecek bir biyobelirteçtir.

Kaynakça

  • Özdemir S, Akça HŞ, Algın A, Altunok İ, Eroğlu SE. Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms. Am J Emerg Med. 2021;49:259-264. doi:10.1016/j.ajem.2021.06.020
  • Özkan A. Ideal predictor studies. J Exp Clin Med. 2022; 39(2): 595-596.
  • Ozdemir S, Akça HŞ, Algın A, Eroğlu SE. Can C-reactive protein-to-albumin ratio be a predictor of short-term mortality in community-acquired pneumonia? Ann Clin Anal Med. 2021;12(9):1043-1048.
  • Özdemir S, Eroğlu SE, Algın A, Akca HS, Ozkan A, Pala E, et al. Analysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital. Ann Clin Anal Med. 2021;12 (Supp 4):518-23. Doi: 10.4328/ACAM.20678.
  • Wang X, Xu Y, Huang H, Jiang D, Zhou C, Liao H, et al. Increased pretreatment C-reactive protein-to-albumin ratio predicts severe coronavirus disease 2019 [Internet]. Research Square; 2020. Available from: https://europepmc.org/article/PPR/PPR198491
  • Karakoyun I, Colak A, Turken M, Altin Z, Arslan FD, Iyilikci V, et al. Diagnostic utility of Creactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021; 91: 107285.
  • Ozdemir S, Algin A. Evaluation of the ability of the C-reactive protein-to-albumin ratio to predict short-term mortality in patients with COVID-19. J Clin Med Kaz. 2021;18(6):35-9. Doi: 10.23950/jcmk/11324.

COVID-19 and C-Reactive Protein Albumin Ratio as a Predictor

Yıl 2022, Cilt: 14 Sayı: 3, 77 - 78, 31.12.2022
https://doi.org/10.35514/mtd.2022.77

Öz

New information comes out every day about the COVID-19 disease, which emerged towards the end of 2019 and affected the whole world in the following periods, causing it to be declared a pandemic. However, the necessity of closer monitoring of the patients during the clinical follow-up and treatment phase of the disease or the determination of which patient group is at higher risk for severe disease becomes more important when the burden on the health system increases during peak periods. It is necessary to make the right triage and bring the right resources to the right patients in situations such as pandemics that affect very large masses and make it difficult to manage resources appropriately in health care delivery. CRP Albumin ratio is a biomarker that can be used in the management of COVID-19 patients because it is easily accessible, inexpensive and simple.

Kaynakça

  • Özdemir S, Akça HŞ, Algın A, Altunok İ, Eroğlu SE. Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms. Am J Emerg Med. 2021;49:259-264. doi:10.1016/j.ajem.2021.06.020
  • Özkan A. Ideal predictor studies. J Exp Clin Med. 2022; 39(2): 595-596.
  • Ozdemir S, Akça HŞ, Algın A, Eroğlu SE. Can C-reactive protein-to-albumin ratio be a predictor of short-term mortality in community-acquired pneumonia? Ann Clin Anal Med. 2021;12(9):1043-1048.
  • Özdemir S, Eroğlu SE, Algın A, Akca HS, Ozkan A, Pala E, et al. Analysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital. Ann Clin Anal Med. 2021;12 (Supp 4):518-23. Doi: 10.4328/ACAM.20678.
  • Wang X, Xu Y, Huang H, Jiang D, Zhou C, Liao H, et al. Increased pretreatment C-reactive protein-to-albumin ratio predicts severe coronavirus disease 2019 [Internet]. Research Square; 2020. Available from: https://europepmc.org/article/PPR/PPR198491
  • Karakoyun I, Colak A, Turken M, Altin Z, Arslan FD, Iyilikci V, et al. Diagnostic utility of Creactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021; 91: 107285.
  • Ozdemir S, Algin A. Evaluation of the ability of the C-reactive protein-to-albumin ratio to predict short-term mortality in patients with COVID-19. J Clin Med Kaz. 2021;18(6):35-9. Doi: 10.23950/jcmk/11324.
Toplam 7 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri
Bölüm Editöre Mektup
Yazarlar

İbrahim Altunok 0000-0002-9312-1025

Yayımlanma Tarihi 31 Aralık 2022
Gönderilme Tarihi 11 Haziran 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 14 Sayı: 3

Kaynak Göster

Vancouver Altunok İ. COVID-19 and C-Reactive Protein Albumin Ratio as a Predictor. Maltepe tıp derg. 2022;14(3):77-8.